Market Overview:
The global nano antibodies market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for targeted therapies and rising prevalence of chronic diseases. Based on type, the global nano antibodies market is segmented into monovalent nanobodies, multivalent and multispecific nanobodies, and fusion nanobodies. Monovalent nanobodies are expected to account for the largest share of the global nano antibodies market in 2018 owing to their high specificity and affinity for their targets. By application, disease detection in vitro is expected to account for the largest share of the global nano antibodies market in 2018 owing to its growing use in drug discovery and development processes.
Product Definition:
Nano antibodies are tiny, synthetic proteins that can bind to specific targets, such as cancer cells. Once bound, nano antibodies can be used to deliver drugs or other therapies directly to the tumor cells. This targeted approach may offer a more effective way to treat cancer than traditional chemotherapy or radiation therapy.
Monovalent Nanobody:
Monovalent nanobody is a new term in the field of biotechnology and it has been defined as any single-stranded, linear or branched DNA molecule that can bind to anionic ligands. Monovalent nanobodies are also known as single-molecule antibodies (SMA). They are engineered to have specific binding properties for their cognate antigens.
Multivalent and multispecific Nanobodies:
Nanobodies are small protein-based molecules that bind to specific targets. They have several advantages over conventional antibodies such as they can be manufactured more economically, they are capable of reaching every corner of the cell and binding with high specificity to a particular target, and most important of all, they do not trigger an immune response in the human body unlike other antibody drugs.
Application Insights:
The disease detection in vitro application segment dominated the global market with a revenue share of over 40% in 2017. The high share is attributed to the rising number of research studies that have proved the diagnostic efficacy of nanobodies for various diseases.
Non-invasive diagnosis in vivo application is expected to witness lucrative growth during the forecast period owing to increasing government funding and initiatives for early diagnosis and treatment options, which are further driving product demand globally. For instance, Nanotechnology Research Centers at UMass Amherst and University College Cork are involved in developing innovative techniques using nanobodies for non-invasive diagnostics based on molecular imaging. Such initiatives by public and private organizations across the world are anticipated to fuel market growth over next few years.
Regional Analysis:
North America dominated the global market in 2017. This is due to the presence of a large number of research laboratories and universities involved in nanobiotechnology research. Moreover, increasing investments by private entities for developing novel diagnostic products are expected to propel growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure and growing demand for improved diagnosis methods that are less invasive as well as cheaper than conventional ones.
Growth Factors:
- Increasing demand for nanotechnology-based products in the healthcare sector
- Rising prevalence of chronic diseases and increasing awareness about nanomedicine therapies
- Growing number of research and development activities for novel nanoantibody therapeutics
- Technological advancements in antibody engineering that enable production of smaller, more stable and potent antibodies
- Increasing investments by pharmaceutical companies in the development of novel nanoantibody drugs
Scope Of The Report
Report Attributes
Report Details
Report Title
Nano Antibodies Market Research Report
By Type
Monovalent Nanobody, Multivalent and multispecific Nanobodies, Fusion Nanobody
By Application
Disease detection in vitro, Non-invasive diagnosis in vivo, Tumor targeted therapy, Nervous system disease, Circulatory disease, Infectious disease, Other
By Companies
Ablynx, PREGENE, Alphamab, PersonGen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
123
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Nano Antibodies Market Report Segments:
The global Nano Antibodies market is segmented on the basis of:
Types
Monovalent Nanobody, Multivalent and multispecific Nanobodies, Fusion Nanobody
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Disease detection in vitro, Non-invasive diagnosis in vivo, Tumor targeted therapy, Nervous system disease, Circulatory disease, Infectious disease, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ablynx
- PREGENE
- Alphamab
- PersonGen
Highlights of The Nano Antibodies Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monovalent Nanobody
- Multivalent and multispecific Nanobodies
- Fusion Nanobody
- By Application:
- Disease detection in vitro
- Non-invasive diagnosis in vivo
- Tumor targeted therapy
- Nervous system disease
- Circulatory disease
- Infectious disease
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nano Antibodies Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Some of the key players operating in the nano antibodies market are Ablynx, PREGENE, Alphamab, PersonGen.
The nano antibodies market is expected to register a CAGR of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nano Antibodies Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nano Antibodies Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nano Antibodies Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nano Antibodies Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nano Antibodies Market Size & Forecast, 2018-2028
4.5.1 Nano Antibodies Market Size and Y-o-Y Growth
4.5.2 Nano Antibodies Market Absolute $ Opportunity
Chapter 5 Global Nano Antibodies Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Nano Antibodies Market Size Forecast by Type
5.2.1 Monovalent Nanobody
5.2.2 Multivalent and multispecific Nanobodies
5.2.3 Fusion Nanobody
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Nano Antibodies Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Nano Antibodies Market Size Forecast by Applications
6.2.1 Disease detection in vitro
6.2.2 Non-invasive diagnosis in vivo
6.2.3 Tumor targeted therapy
6.2.4 Nervous system disease
6.2.5 Circulatory disease
6.2.6 Infectious disease
6.2.7 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nano Antibodies Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nano Antibodies Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Nano Antibodies Analysis and Forecast
9.1 Introduction
9.2 North America Nano Antibodies Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Nano Antibodies Market Size Forecast by Type
9.6.1 Monovalent Nanobody
9.6.2 Multivalent and multispecific Nanobodies
9.6.3 Fusion Nanobody
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Nano Antibodies Market Size Forecast by Applications
9.10.1 Disease detection in vitro
9.10.2 Non-invasive diagnosis in vivo
9.10.3 Tumor targeted therapy
9.10.4 Nervous system disease
9.10.5 Circulatory disease
9.10.6 Infectious disease
9.10.7 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Nano Antibodies Analysis and Forecast
10.1 Introduction
10.2 Europe Nano Antibodies Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Nano Antibodies Market Size Forecast by Type
10.6.1 Monovalent Nanobody
10.6.2 Multivalent and multispecific Nanobodies
10.6.3 Fusion Nanobody
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Nano Antibodies Market Size Forecast by Applications
10.10.1 Disease detection in vitro
10.10.2 Non-invasive diagnosis in vivo
10.10.3 Tumor targeted therapy
10.10.4 Nervous system disease
10.10.5 Circulatory disease
10.10.6 Infectious disease
10.10.7 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Nano Antibodies Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Nano Antibodies Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Nano Antibodies Market Size Forecast by Type
11.6.1 Monovalent Nanobody
11.6.2 Multivalent and multispecific Nanobodies
11.6.3 Fusion Nanobody
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Nano Antibodies Market Size Forecast by Applications
11.10.1 Disease detection in vitro
11.10.2 Non-invasive diagnosis in vivo
11.10.3 Tumor targeted therapy
11.10.4 Nervous system disease
11.10.5 Circulatory disease
11.10.6 Infectious disease
11.10.7 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Nano Antibodies Analysis and Forecast
12.1 Introduction
12.2 Latin America Nano Antibodies Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Nano Antibodies Market Size Forecast by Type
12.6.1 Monovalent Nanobody
12.6.2 Multivalent and multispecific Nanobodies
12.6.3 Fusion Nanobody
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Nano Antibodies Market Size Forecast by Applications
12.10.1 Disease detection in vitro
12.10.2 Non-invasive diagnosis in vivo
12.10.3 Tumor targeted therapy
12.10.4 Nervous system disease
12.10.5 Circulatory disease
12.10.6 Infectious disease
12.10.7 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Nano Antibodies Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Nano Antibodies Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Nano Antibodies Market Size Forecast by Type
13.6.1 Monovalent Nanobody
13.6.2 Multivalent and multispecific Nanobodies
13.6.3 Fusion Nanobody
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Nano Antibodies Market Size Forecast by Applications
13.10.1 Disease detection in vitro
13.10.2 Non-invasive diagnosis in vivo
13.10.3 Tumor targeted therapy
13.10.4 Nervous system disease
13.10.5 Circulatory disease
13.10.6 Infectious disease
13.10.7 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nano Antibodies Market: Competitive Dashboard
14.2 Global Nano Antibodies Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ablynx
14.3.2 PREGENE
14.3.3 Alphamab
14.3.4 PersonGen
